News
12-13-2009, 11:41 PM
bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.
More... (http://www.news-medical.net/news/20091214/Findings-from-three-studies-using-bioTheranostics-breast-cancer-molecular-test-reported.aspx)
More... (http://www.news-medical.net/news/20091214/Findings-from-three-studies-using-bioTheranostics-breast-cancer-molecular-test-reported.aspx)